Tobias Schmidt Slørdahl

12PUBLICATIONS
33CO-AUTHORS
Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical mycologyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 12, 2026
Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

|Feb 24, 2026
Multiplexed Imaging Reveals Immune-Metabolic Niches in Multiple Myeloma Linked to Progression and Bone Disease.

Ingrid Aass Roseth, Lukas Hatscher, Chiara Schiller

|Dec 22, 2025
Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.

Frida Bugge Askeland, Vilhelm Hauge Bugge, Anne-Marie Rasmussen

|Apr 08, 2025
A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma.

Christian Brieghel, Tobias Schmidt Slørdahl, Morten Nørgaard Andersen

|Jan 27, 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone.

Tobias S Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen

|Aug 19, 2024
Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experience.

Marie Røra, Margrete Skretting Solberg, Kari Lenita Falck Moore

Pageof 2

Frequent Collaborators

6 joint publications

Fredrik Schjesvold

4 joint publications

Anders Waage

2 joint publications

Annette Juul Vangsted

2 joint publications

Agoston Gyula Szabo